Anika Therapeutics, Inc. (ANIK)
NASDAQ: ANIK · Real-Time Price · USD
17.39
-0.26 (-1.47%)
Feb 21, 2025, 4:00 PM EST - Market closed
Anika Therapeutics Employees
Anika Therapeutics had 357 employees as of December 31, 2023. The number of employees increased by 12 or 3.48% compared to the previous year.
Employees
357
Change (1Y)
12
Growth (1Y)
3.48%
Revenue / Employee
$459,854
Profits / Employee
-$273,165
Market Cap
254.69M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
ANIK News
- 2 months ago - Anika To Participate in 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 3 months ago - Anika To Participate in December 2024 Investor Conferences - GlobeNewsWire
- 3 months ago - Anika Therapeutics, Inc. (ANIK) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Arthrosurface Returns to it Roots Following Divestiture from Anika Therapeutics - PRNewsWire
- 4 months ago - Anika Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 4 months ago - Anika Announces Strategic Update of Business with Sale of Arthrosurface and Plan to Divest Parcus Medical - GlobeNewsWire
- 4 months ago - Anika Announces Third Quarter 2024 Results Conference Call Date - GlobeNewsWire
- 5 months ago - Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire